高毒力肺炎克雷伯菌致原发性肺炎及脓胸一例并文献复习
Primary Pneumonia and Empyema Caused by Hypervirulent Klebsiella pneumoniae: A Case Report and Literature Review
DOI: 10.12677/acm.2024.14123111, PDF,   
作者: 邵亚平, 高海祥*:华北理工大学研究生院,河北 唐山;河北省人民医院呼吸与危重症医学科,河北 石家庄;赵培硕:河北省人民医院呼吸与危重症医学科,河北 石家庄;河北医科大学研究生院,河北 石家庄;高树会, 闫 莉:河北省人民医院呼吸与危重症医学科,河北 石家庄;乔 童:河北省人民医院呼吸与危重症医学科,河北 石家庄;河北北方学院研究生院,河北 张家口
关键词: 肺部感染高毒力肺炎克雷伯菌宏基因二代测序脓胸Pulmonary Infection Hypervirulent Klebsiella pneumoniae Metagenomics Next-Generation Sequencing Empyema
摘要: 肺炎克雷伯菌(Klebsiella pneumoniae, KP),是一种临床常见的革兰阴性杆菌,作为肠杆菌科细菌中重要的致病菌可引起社区及医院获得性感染,导致肺炎、肝脓肿、泌尿系统感染以及血流感染等多种感染性疾病。高毒力肺炎克雷伯菌(hypervirulent Klebsiella pneumoniae, hvKP)是肺炎克雷伯菌的新型高毒力变种,其显著特征是高黏液表型。与经典肺炎克雷伯菌(classical Klebsiella pneumoniae, cKP)相比,hvKP毒力更强,而非机会致病菌,多在健康人群中引起社区获得性感染。本文报道了一名老年免疫功能正常的女性患者,因咳嗽咳痰4天,气短伴发热2天入院,通过胸腔积液及血液(bronchoalveolar lavage fluid, BALF)送检宏基因组二代测序(metagenomics Next-Generation Sequencing, mNGS)鉴定出高毒力肺炎克雷伯菌感染,采用输注亚胺培南西司他丁、多粘菌素B控制感染的病例,进一步提高临床对该病的认识。
Abstract: Klebsiella pneumoniae (KP) is a common gram-negative bacillus. As an important pathogen of Enterobacteriaceae bacteria, it can cause community-acquired and hospital-acquired infections, leading to pneumonia, liver abscess, urinary tract infection, bloodstream infection and other infectious diseases. Hypervirulent Klebsiella pneumoniae (hvKP) is a new type of high virulence in Klebsiella pneumoniae variant, and its characteristic is a high slime phenotype. Compared to classical Klebsiella pneumoniae (cKP), hypervirulent Klebsiella pneumoniae (hvKP) exhibits stronger virulence and is not an opportunistic pathogen. Instead, it predominantly causes community-acquired infections in healthy populations. This article reports a case of an elderly female patient with normal immune function who was admitted to the hospital due to intermittent cough with expectoration for 4 days and shortness of breath accompanied by fever for 2 days. Metagenomics Next-Generation Sequencing (mNGS) of pleural effusion and bronchoalveolar lavage fluid (BALF) identified infection with hypervirulent Klebsiella pneumoniae. The infection was controlled with intravenous infusions of imipenem/cilastatin and polymyxin B. This case aims to further enhance clinical awareness of this disease.
文章引用:邵亚平, 赵培硕, 高树会, 乔童, 高海祥, 闫莉. 高毒力肺炎克雷伯菌致原发性肺炎及脓胸一例并文献复习[J]. 临床医学进展, 2024, 14(12): 511-517. https://doi.org/10.12677/acm.2024.14123111

参考文献

[1] Chang, D., Sharma, L., Dela Cruz, C.S. and Zhang, D. (2021) Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Frontiers in Microbiology, 12, Article ID: 750662. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, Y.C., Cheng, D.L. and Lin, C.L. (1986) Klebsiella pneumoniae Liver Abscess Associated with Septic Endophthalmitis. Archives of Internal Medicine, 146, 1913-1916. [Google Scholar] [CrossRef] [PubMed]
[3] 黄韵, 李从荣. 高毒力肺炎克雷伯菌研究进展[J]. 检验医学, 2021, 36(11): 1181-1185.
[4] Russo, T.A. and Marr, C.M. (2019) Hypervirulent Klebsiella pneumoniae. Clinical Microbiology Reviews, 32, e00001-19. [Google Scholar] [CrossRef] [PubMed]
[5] Siu, L.K., Yeh, K., Lin, J., Fung, C. and Chang, F. (2012) Klebsiella pneumoniae Liver Abscess: A New Invasive Syndrome. The Lancet Infectious Diseases, 12, 881-887. [Google Scholar] [CrossRef] [PubMed]
[6] 吴柳, 陈蓓, 张洁, 等. 肺炎克雷伯菌引起的多发性脓肿1例[J]. 中国感染与化疗杂志, 2018, 18(3): 315-318.
[7] Russo, T.A., Olson, R., Fang, C., Stoesser, N., Miller, M., MacDonald, U., et al. (2018) Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae. Journal of Clinical Microbiology, 56, e00776-18. [Google Scholar] [CrossRef] [PubMed]
[8] Wyres, K.L., Wick, R.R., Gorrie, C., Jenney, A., Follador, R., Thomson, N.R., et al. (2016) Identification of Klebsiella Capsule Synthesis Loci from Whole Genome Data. Microbial Genomics, 2, e000102. [Google Scholar] [CrossRef] [PubMed]
[9] Choby, J.E., Howard‐Anderson, J. and Weiss, D.S. (2019) Hypervirulent Klebsiella pneumoniae—Clinical and Molecular Perspectives. Journal of Internal Medicine, 287, 283-300. [Google Scholar] [CrossRef] [PubMed]
[10] Merchant, N. and Liu, C. (2024) Thoracic Empyema: Aetiology, Diagnosis, Treatment, and Prevention. Current Opinion in Pulmonary Medicine, 30, 204-209. [Google Scholar] [CrossRef] [PubMed]
[11] Musher, D.M., Gorbach, S. and Fierer, J. (2024) Pleural Empyema: Etiology and Pathogenesis. Clinical Infectious Diseases, ciae102. [Google Scholar] [CrossRef] [PubMed]
[12] Pinnola, A., Kuo, Y., Sciarretta, J.D., Mcintyre, A., Messier, R. and Davis, J.M. (2018) Bacteriology and Comorbidities in Patients Requiring Surgical Management of Empyema. The American Surgeon™, 84, 599-603. [Google Scholar] [CrossRef
[13] 牙俊锋, 翟永富, 贺强军, 等. 尿激酶胸腔内注射冲洗用于脓胸留置引流的临床效果[J]. 临床合理用药, 2023, 16(1): 67-69.
[14] 于明子, 梁志欣. 复杂性胸腔积液和脓胸诊治新进展[J]. 中华医院感染学杂志, 2020, 30(17): 2717-2720.
[15] 张海洋, 韩晶, 王中天, 等. 高毒力肺炎克雷伯菌致病、耐药机制及其治疗研究进展[J]. 中国病原生物学杂志, 2024, 19(10): 1239-1243+1247.
[16] 蒋玉婷, 张珂, 刘唐娟, 等. 高毒力肺炎克雷伯菌毒力和耐药机制研究进展[J]. 中国感染控制杂志, 2021, 20(5): 473-480.